LIX1L and cancer: Therefore, the discovery of an inhibitor of LIX1L, such as shRNA, homeodomain peptides and inhibitors of specific ROS1 kinases would be useful to identify potential tumor-specific drugs for LIX1L-expressing cancer cells.